Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer

BACKGROUND: Current diagnosis and staging of pancreatic ductal adenocarcinoma (PDAC) has important limitations and better biomarkers are needed to guide initial therapy. We investigated the performance of circulating tumour cells (CTCs) as an adjunctive biomarker at the time of disease presentation....

Descripción completa

Detalles Bibliográficos
Autores principales: Ankeny, J S, Court, C M, Hou, S, Li, Q, Song, M, Wu, D, Chen, J F, Lee, T, Lin, M, Sho, S, Rochefort, M M, Girgis, M D, Yao, J, Wainberg, Z A, Muthusamy, V R, Watson, R R, Donahue, T R, Hines, O J, Reber, H A, Graeber, T G, Tseng, H R, Tomlinson, J S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984454/
https://www.ncbi.nlm.nih.gov/pubmed/27300108
http://dx.doi.org/10.1038/bjc.2016.121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984454/
https://www.ncbi.nlm.nih.gov/pubmed/27300108
http://dx.doi.org/10.1038/bjc.2016.121

Ejemplares similares